Meningococcal disease: Clinical presentation and sequelae

Vaccine

Volumn 30, Issue SUPPL. 2, 2012, Pages

  Pace, David ^a   Pollard, Andrew J ^b  

^a MATER DEI HOSPITAL   (Malta)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Invasive meningococcal disease; Neisseria meningitidis; Sequelae

Indexed keywords

ENDOTOXIN; MENINGOCOCCUS VACCINE;

AMPUTATION; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL COLONIZATION; BACTERIAL MENINGITIS; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BEHAVIOR CHANGE; CARDITIS; CHRONIC PAIN; COMMON COLD; CONJUNCTIVITIS; DECREASED APPETITE; EPISCLERITIS; FULMINATING PURPURA; GENETIC POLYMORPHISM; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; INFECTION SENSITIVITY; INFLAMMATION; IRITIS; IRRITABILITY; LIMB PAIN; MACULOPAPULAR RASH; MENINGOCOCCEMIA; MENINGOCOCCOSIS; MOTOR DYSFUNCTION; NAUSEA AND VOMITING; NEISSERIA MENINGITIDIS; NEUROLOGIC DISEASE; PERICARDIAL EFFUSION; PHARYNGITIS; PLEURISY; PRIORITY JOURNAL; QUALITY OF LIFE; SCAR FORMATION; SEIZURE; SEPTICEMIA; SOCIAL BEHAVIOR; SURVIVOR; UPPER RESPIRATORY TRACT INFECTION; VASCULITIS; VISUAL IMPAIRMENT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONJUNCTIVITIS; HUMANS; INFANT; MENINGITIS, BACTERIAL; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MENTAL DISORDERS; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 84861112194     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.062     Document Type: Article

References (108)

1. Centers for Disease Control and Prevention. Active bacterial core surveillance (ABCs): surveillance reports Neisseria meningitidis, ; 1999-2009 [accessed 06.09.11]. http://www.cdc.gov/abcs/reports-findings/surv-reports.html.
2. European Centre for Disease Prevention and Control Annual epidemiological report on communicable diseases in Europe 2010 2010, ECDC, Stockholm.
3. Greenwood B. Manson lecture meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 1999, 93(4):341-353.
4. Mutonga D.M., Pimentel G., Muindi J., Nzioka C., Mutiso J., Klena J.D., et al. Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006. Am J Trop Med Hyg 2009, 80(4):619-624.
5. Trotter C.L., Chandra M., Cano R., Larrauri A., Ramsay M.E., Brehony C., et al. A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev 2007, 31(1):27-36.
6. Bilukha O.O., Rosenstein N. National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005, 54(RR-7):1-21.
7. Swartz M.N. Bacterial meningitis - a view of the past 90 years. N Engl J Med 2004, 351(October (18)):1826-1828.
8. Kirsch E.A., Barton R.P., Kitchen L., Giroir B.P. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J 1996, 15:967-979.
9. Vieusseux G. Mémoire sur la maladie qui a régné a Genève au printemps de 1805. J Med Chir Pharm 1805, 11:163-182. (Article in French).
10. Danielson L., Mann E. The history of a singular and very mortal disease, which lately made its appearance in Medfield. Med Agric Reg 1806, 1:65.
11. Weichselbaum A. Ueber die aetiologie der akuten meningitis cerebro-spinalis epidemica. Fortschr Med 1887, 5. 573-583, 620-626. (Article in German).
12. Kiefer F. Zur differential diagnose des erregers der epidemischen cerebrospinalmeningitis und der gonorrhoea. Berl Klin Wochenschr 1896, 33:628-630. (Article in German).
13. Chalmers A.J., O'Farrell W.R. Preliminary remarks upon epidemic cerebrospinal meningitis as seen in the Anglo-Egyptian Sudan. J Trop Med Hyg 1916, 29:101-129.
14. Ensor H., Balfour A. A case of cerebro-spinal meningitis. J R Army Med Corps 1904, 3:667-670.
15. McGahey K. Report on an outbreak of epidemic cerebrospinal meningitis in Zungeru during February and March 1905. J Trop Med 1905, 8:210-216.
16. McGahey K. Report of the outbreak of cerebrospinal meningitis at Yola. J Trop Med 1905, 8:216-217.
17. Greenwood B. Editorial: 100 years of epidemic meningitis in West Africa - has anything changed?. Trop Med Int Health 2006, 11(6):773-780.
18. Flexner S. The results of the serum treatment in 1300 cases of epidemic meningitis. J Exp Med 1913, 17:553-576.
19. Flexner S., Jobling J.W. Serum treatment of epidemic cerebro-spinal meningitis. J Exp Med 1908, 10:141-195.
20. Walsh G. Fatality rates in cerebrospinal meningitis. JAMA 1938, 110:1894-1896.
21. Banks H.S. Serum and sulphanilamide in acute meningococcal meningitis. Lancet 1938, 2:7-13.
22. Millar J.W., Siess E.E., Feldman H.A., Silverman C., Frank P. In vivo and in vitro resistance to sulfadiazine in strains of Neisseria meningitidis. JAMA 1963, 186:139-141.
23. Cartwright K.A., Stuart J.M., Jones D.M., Noah N.D. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987, 99:591-601.
24. Trotter C.L., Greenwood B.M. Meningococcal carriage in the African meningitis belt. Lancet Infect Dis 2007, 7(12):797-803.
25. Gold R., Goldschneider I., Lepow M.L., Draper T.F., Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 1978, 137(2):112-121.
26. Claus H., Maiden M.C., Wilson D.J., McCarthy N.D., Jolley K.A., Urwin R., et al. Genetic analysis of meningococci carried by children and young adults. J Infect Dis 2005, 191(8):1263-1271.
27. Sivonen A., Renkonen O.V., Weckström P., Koskenvuo K., Raunio V., Mäkelä P.H. The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland. J Infect Dis 1978, 137(March (3)):238-244.
28. Wilder-Smith A., Barkham T.M., Earnest A., Paton N.I. Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study. BMJ 2002, 325:365-366.
29. MacLennan J., Kafatos G., Neal K., Andrews N., Cameron J.C., Roberts R., et al. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis 2006, 12(6):950-957. United Kingdom Meningococcal Carriage Group.
30. Bagaitkar J., Demuth D.R., Scott D.A. Tobacco use increases susceptibility to bacterial infection. Tob Induc Dis 2008, 4:12.
31. Moore P.S., Hierholzer J., DeWitt W., Gouan K., Djoré D., Lippeveld T., et al. Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA 1990, 264(10):1271-1275.
32. Jarva H., Ram S., Vogel U., Blom A.M., Meri S. Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis. J Immunol 2005, 174(10):6299-6307.
33. Whalen C.M., Hockin J.C., Ryan A., Ashton F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA 1995, 273(February (5)):390-394.
34. Mayer L.W., Reeves M.W., Al-Hamdan N., Sacchi C.T., Taha M.K., Ajello G.W., et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electrophoretic type-37 complex. J Infect Dis 2002, 185(11):1596-1605.
35. Kinlin L.M., Spain C.V., Ng V., Johnson C.C., White A.N., Fisman D.N. Environmental exposures and invasive meningococcal disease: an evaluation of effects on varying time scales. Am J Epidemiol 2009, 169(5):588-595.
36. Molesworth A.M., Cuevas L.E., Connor S.J., Morse A.P., Thomson M.C. Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis 2003, 9(10):1287-1293.
37. Cookson S.T., Corrales J.L., Lotero J.O., Regueira M., Binsztein N., Reeves M.W., et al. Disco fever: epidemic meningococcal disease in northeastern Argentina associated with disco patronage. J Infect Dis 1998, 178(July (1)):266-269.
38. De Wals P., Hertoghe L., Borlée-Grimée I., De Maeyer-Cleempoel S., Reginster-Haneuse G., Dachy A., et al. Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts. J Infect 1981, 3(March (Suppl. (1))):53-61.
39. Holdsworth R.J., Irving A.D., Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991, 78(September (9)):1031-1038.
40. Fijen C.A., Kuijper E.J., Hannema A.J., Sjöholm A.G., van Putten J.P. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet 1989, 2(September (8663)):585-588.
41. Edwards E.A., Devine L.F., Sengbusch G.H., Ward H.W. Immunological investigations of meningococcal disease. III: brevity of group C acquisition prior to disease occurrence. Scand J Infect Dis 1977, 9(2):105-110.
42. Munford R.S., Taunay Ade E., de Morais J.S., Fraser D.W., Feldman R.A. Spread of meningococcal infection within households. Lancet 1974, 1(June (7869)):1275-1278.
43. Cooke R.P., Riordan T., Jones D.M., Painter M.J. Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-87. BMJ 1989, 298(March (6673)):555-558.
44. Sullivan T.D., LaScolea L.J Neisseria meningitidis bacteremia in children: quantitation of bacteremia and spontaneous clinical recovery without antibiotic therapy. Pediatrics 1987, 80(1):63-67.
45. Darton T., Guiver M., Naylor S., Jack D.L., Kaczmarski E.B., Borrow R., et al. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis 2009, 48(March (5)):587-594.
46. Wright V., Hibberd M., Levin M. Genetic polymorphisms in host response to meningococcal infection: the role of susceptibility and severity genes. Vaccine 2009, 27(Suppl. 2):B90-B102.
47. Thompson M.J., Ninis N., Perera R., Mayon-White R., Phillips C., Bailey L., et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006, 367(9508):397-403.
48. Nassif X. Interaction mechanisms of encapsulated meningococci with eukaryotic cells: what does this tell us about the crossing of the blood-brain barrier by Neisseria meningitidis?. Curr Opin Microbiol 1999, 2(1):71-77.
49. European Union invasive bacterial infections surveillance network: invasive Neisseria meningitidis in Europe - 2006 2008, April, EU-IBIS Network Company Publication.
50. Brandtzaeg P., Halstensen A., Kierulf P., Espevik T., Waage A. Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microb Pathog 1992, 13(6):423-431.
51. Ragunathan L., Ramsay M., Borrow R., Guiver M., Gray S., Kaczmarski E.B. Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis: 1997 survey report. J Infect 2000, 40(1):74-79.
52. Geiseler P.J., Nelson K.E., Levin S., Reddi K.T., Moses V.K. Community-acquired purulent meningitis: a review of 1316 cases during the antibiotic era, 1954-1976. Rev Infect Dis 1980, 2(5):725-745.
53. Aponso D., Bullen C. Presenting features of meningococcal disease, public health messages and media publicity: are they consistent?. N Z Med J 2001, 114(1127):83-85.
54. Wong V.K., Hitchcock W., Mason W.H. Meningococcal infections in children: a review of 100 cases. Pediatr Infect Dis J 1989, 8(4):224-227.
55. Voss L., Lennon D., Sinclair J. The clinical features of paediatric meningococcal disease Auckland, 1985-87. N Z Med J 1989, 102(868):243-245.
56. Molyneux E., Riordan F.A., Walsh A. Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference. Ann Trop Paediatr 2006, 26(1):29-37.
57. Valmari P., Peltola H., Ruuskanen O., Korvenranta H. Childhood bacterial meningitis: initial symptoms and signs related to age, and reasons for consulting a physician. Eur J Pediatr 1987, 146(5):515-518.
58. Riordan F.A., Thomson A.P., Sills J.A., Hart C.A. Bacterial meningitis in the first three months of life. Postgrad Med J 1995, 71(831):36-38.
59. Shepard C.W., Rosenstein N.E., Fischer M. Neonatal meningococcal disease in the United States, 1990-1999. Pediatr Infect Dis J 2003, 22(5):418-422. Active Bacterial Core Surveillance Team.
60. Neuman H.B., Wald E.R. Bacterial meningitis in childhood at the Children's Hospital of Pittsburgh: 1988-1998. Clin Pediatr (Phila) 2001, 40(11):595-600.
61. Granier S., Owen P., Stott N.C. Recognizing meningococcal disease: the case for further research in primary care. Br J Gen Pract 1998, 48(429):1167-1171.
62. Marzouk O., Thomson A.P., Sills J.A., Hart C.A., Harris F. Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child 1991, 66(4):485-487.
63. Devoe I.W., Gilchrist J.E. Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J Exp Med 1973, 138(5):1156-1167.
64. Pathan N., Faust S.N., Levin M. Pathophysiology of meningococcal meningitis and septicaemia. Arch Dis Child 2003, 88(7):601-607.
65. Kuppermann N., Malley R., Inkelis S.H., Fleisher G.R. Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease. Pediatrics 1999, 103(2):E20.
66. Shapiro E.D., Aaron N.H., Wald E.R., Chiponis D. Risk factors for development of bacterial meningitis among children with occult bacteremia. Pediatrics 1986, 109(1):15-19.
67. Mandl K.D., Stack A.M., Fleisher G.R. Incidence of bacteremia in infants and children with fever and petechiae. J Pediatr 1997, 131(3):398-404.
68. Van Nguyen Q., Nguyen E.A., Weiner L.B. Incidence of invasive bacterial disease in children with fever and petechiae. Pediatrics 1984, 74(1):77-80.
69. Wells L.C., Smith J.C., Weston V.C., Collier J., Rutter N. The child with a non-blanching rash: how likely is meningococcal disease?. Arch Dis Child 2001, 85(3):218-222.
70. Brogan P.A., Raffles A. The management of fever and petechiae: making sense of rash decisions. Arch Dis Child 2000, 83(6):506-507.
71. Vienne P., Ducos-Galand M., Guiyoule A., Pires R., Giorgini D., Taha M.K., et al. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis 2003, 37(12):1639-1642.
72. Winstead J.M., McKinsey D.S., Tasker S., De Groote M.A., Baddour L.M. Meningococcal pneumonia: characterization and review of cases seen over the past 25 years. Clin Infect Dis 2000, 30(1):87-94.
73. Baevsky R.H. Primary meningococcal pericarditis. Clin Infect Dis 1999, 29(1):213-215.
74. Barquet N., Gasser I., Domingo P., Moraga F.A., Macaya A., Elcuaz R. Primary meningococcal conjunctivitis: report of 21 patients and review. Rev Infect Dis 1990, 12(5):838-847.
75. Benoit F.L. Chronic meningococcemia. Case report and review of the literature. Am J Med 1963, 35:103-112.
76. Brouwer M.C., Spanjaard L., Prins J.M., van der Ley P., van de Beek D., van der Ende A. Association of chronic meningococcemia with infection by meningococci with underacylated lipopolysaccharide. J Infect 2011, 62(6):479-483.
77. Harwood C.A., Stevens J.C., Orton D., Bull R.C., Paige D., Lessing M.P., et al. Chronic meningococcaemia: a forgotten meningococcal disease. Br J Dermatol 2005, 153(3):669-671.
78. Nielsen H.E., Koch C., Mansa B., Magnussen P., Bergmann O.J. Complement and immunoglobulin studies in 15 cases of chronic meningococcemia: properdin deficiency and hypoimmunoglobulinemia. Scand J Infect Dis 1990, 22(1):31-36.
79. Fasano M.B., Sullivan K., Ibsen L., Winkelstein J.A. Chronic meningococcemia in a child with a deficiency of the sixth component of complement. Pediatr Allergy Immunol 1993, 4(4):214-216.
80. Fransen F., Heckenberg S.G., Hamstra H.J., Feller M., Boog C.J., van Putten J.P., et al. Naturally occurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog 2009, 5(April (4)):e1000396.
81. Greenwood B.M., Whittle H.C., Bryceson A.D. Allergic complications of meningococcal disease. II: immunological investigations. Br Med J 1973, 2(5869):737-740.
82. Whittle H.C., Abdullahi M.T., Fakunle F.A., Greenwood B.M., Bryceson A.D., Parry E.H., et al. Allergic complications of meningococcal disease. I: clinical aspects. Br Med J 1973, 2(5869):733-737.
83. Goedvolk C.A., von Rosenstiel I.A., Bos A.P. Immune complex associated complications in the subacute phase of meningococcal disease: incidence and literature review. Arch Dis Child 2003, 88(10):927-930.
84. Faye A., Mariani-Kurkdjian P., Taha M.K., Angoulvant F., Antonios M., Aubertin G., et al. Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases. Clin Infect Dis 2004, 38(June (11)):1635-1637.
85. Edwards M.S., Baker C.J. Complications and sequelae of meningococcal infections in children. J Pediatr 1981, 99(4):540-545.
86. Erickson L., De Wals P. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994. Clin Infect Dis 1998, 26(5):1159-1164.
87. Healy C.M., Butler K.M., Smith E.O., Hensey O.P., Bate T., Moloney A.C., et al. Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000. Clin Infect Dis 2002, 34(10):1323-1330.
88. National Institute for Health and Clinical Excellence. Bacterial meningitis and meningococcal septicaemia: management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care (Clinical guideline 102), ; 2010 [accessed 06.09.11]. http://www.nice.org.uk/CG102.
89. Fellick J.M., Sills J.A., Marzouk O., Hart C.A., Cooke R.W., Thomson A.P. Neurodevelopmental outcome in meningococcal disease: a case-control study. Arch Dis Child 2001, 85(1):6-11.
90. Kaplan S.L., Schutze G.E., Leake J.A., Barson W.J., Halasa N.B., Byington C.L., et al. Multicenter surveillance of invasive meningococcal infections in children. Pediatrics 2006, 118(4):e979-e984.
91. Buysse C.M., Raat H., Hazelzet J.A., Hulst J.M., Cransberg K., Hop W.C., et al. Long-term health status in childhood survivors of meningococcal septic shock. Arch Pediatr Adolesc Med 2008, 162(11):1036-1041.
92. Koomen I., van Furth A.M., Kraak M.A., Grobbee D.E., Roord J.J., Jennekens-Schinkel A. Neuropsychology of academic and behavioural limitations in school-age survivors of bacterial meningitis. Dev Med Child Neurol 2004, 46(11):724-732.
93. Edmond K., Clark A., Korczak V.S., Sanderson C., Griffiths U.K., Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10(5):317-328.
94. Douglas S.A., Sanli H., Gibson W.P. Meningitis resulting in hearing loss and labyrinthitis ossificans - does the causative organism matter?. Cochlear Implants Int 2008, 9(2):90-96.
95. Ramakrishnan M., Ulland A.J., Steinhardt L.C., Moïsi J.C., Were F., Levine O.S. Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med 2009, 14(September (7)):47.
96. Buysse C.M., Oranje A.P., Zuidema E., Hazelzet J.A., Hop W.C., Diepstraten A.F., et al. Long-term skin scarring and orthopaedic sequelae in survivors of meningococcal septic shock. Arch Dis Child 2009, 94(5):381-386.
97. Belthur M.V., Bradish C.F., Gibbons P.J. Late orthopaedic sequelae following meningococcal septicaemia. A multicentre study. J Bone Joint Surg Br 2005, 87(2):236-240.
98. Slack R., Hawkins K.C., Gilhooley L., Addison G.M., Lewis M.A., Webb N.J. Long-term outcome of meningococcal sepsis-associated acute renal failure. Pediatr Crit Care Med 2005, 6(4):477-479.
99. Schiffl H., Fischer R. Five-year outcomes of severe acute kidney injury requiring renal replacement therapy. Nephrol Dial Transplant 2008, 23(7):2235-2241.
100. Haines C. Parents' experiences of living through their child's suffering from and surviving severe meningococcal disease. Nurs Crit Care 2005, 10(2):78-89.
101. Buysse C.M., Raat H., Hazelzet J.A., Hop W.C., Maliepaard M., Joosten K.F. Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge. Crit Care Med 2008, 36(2):596-602.
102. Shears D., Nadel S., Gledhill J., Garralda M.E. Short-term psychiatric adjustment of children and their parents following meningococcal disease. Pediatr Crit Care Med 2005, 6(1):39-43.
103. Garralda M.E., Gledhill J., Nadel S., Neasham D., O'Connor M., Shears D. Longer-term psychiatric adjustment of children and parents after meningococcal disease. Pediatr Crit Care Med 2009, 10(6):675-680.
104. Turner N.M., York D.G., Petousis-Harris H.A. The use and misuse of media headlines: lessons from the MeNZB immunisation campaign. N Z Med J 2009, 122(1291):22-27.
105. Timmermans D.R., Henneman L., Hirasing R.A., van der Wal G. Parents' perceived vulnerability and perceived control in preventing meningococcal C infection: a large-scale interview study about vaccination. BMC Public Health 2008, 8:45.
106. Davis K.L., Bell T.J., Miller J.M., Misurski D.A., Bapat B. Hospital costs, length of stay and mortality associated with childhood, adolescent and young adult meningococcal disease in the US. Appl Health Econ Health Policy 2011, 9(3):197-207.
107. Raine J.E. An analysis of successful litigation claims in children in England. Arch Dis Child 2011, 96(9):838-840.
108. Wrenn K.D. Meningococcal sequelae. Ann Emerg Med 1996, 28(2):239-240.